Diferencia entre revisiones de «Acute pain management»
Sin resumen de edición |
(Add verified PubMed references (PMIDs 35636044)) |
||
| (No se muestran 21 ediciones intermedias de 8 usuarios) | |||
| Línea 1: | Línea 1: | ||
=== WHO 3-step Ladder for Pain Control | ===Opioid Epidemic=== | ||
*Consider that with a 10-day supply of an initial opioid prescription, the odds of still being on opioids a year later is ~20%<ref>Rech MA, et al. Acute pain management in the Emergency Department: Use of multimodal and non-opioid analgesic treatment strategies. Am J Emerg Med. 2022 Aug;58:57-65. PMID 35636044</ref> | |||
*Consider [[opioid free]] regimens | |||
[[File:Opioid_abuse_graph.png|thumb|Continued Opioid Use After First Prescription]] | |||
===WHO 3-step Ladder for Pain Control=== | |||
{| class="wikitable" | {| class="wikitable" | ||
|- | |- | ||
| Línea 6: | Línea 11: | ||
! scope="col" | Parenteral | ! scope="col" | Parenteral | ||
|- | |- | ||
| colspan="2" | '''Step1. Mild Pain, | | colspan="2" | '''Step1. Mild Pain, Nonopioid, +/- Adjuvant''' | ||
| | | | ||
|- | |- | ||
| [[Acetaminophen]] | | [[Acetaminophen]] | ||
| 650mg q4-q6h | | 650mg q4-q6h PRN or 1000mg q6h PRN | ||
| - | | - | ||
|- | |- | ||
| [[Aspirin]] | | [[Aspirin]] | ||
| 650mg q4-6h | | 650mg q4-6h PRN or 1000mg q6h PRN | ||
| - | | - | ||
|- | |- | ||
| [[Ibuprofen]]<span class="Apple-tab-span" style="white-space:pre"> </span> | | [[Ibuprofen]]<span class="Apple-tab-span" style="white-space:pre"> </span> | ||
| 400-800mg q6-8h | | 400-800mg q6-8h PRN | ||
| - | | - | ||
|- | |- | ||
| Línea 25: | Línea 30: | ||
| - | | - | ||
|- | |- | ||
| colspan="2" | '''Step2. Mod Pain, [[ | | colspan="2" | '''Step2. Mod Pain, [[Opioid]] for mild/mod pain, +/-nonopioid, +/-Adjuvant''' | ||
| | | | ||
|- | |- | ||
| [[Hydrocodone]] (5mg/[[Acetaminophen]] 325mg) | | [[Hydrocodone]] (5mg/[[Acetaminophen]] 325mg) | ||
| 1-2 tabs PO q4-6h | | 1-2 tabs PO q4-6h PRN | ||
| - | | - | ||
|- | |- | ||
| [[Oxycodone]] (5mg/ | | [[Oxycodone]] (5mg/[[Acetaminophen]] 325mg) | ||
| 1-2 tabs PO q4h | | 1-2 tabs PO q4h PRN | ||
| - | | - | ||
|- | |- | ||
| Línea 44: | Línea 49: | ||
| - | | - | ||
|- | |- | ||
| colspan="2" | '''Step3. Severe Pain, | | colspan="2" | '''Step3. Severe Pain, Opioid for mod/sev pain, +/- nonopioid, +/-Adjuvant''' | ||
| | | | ||
|- | |- | ||
| [[Morphine]] | | [[Morphine]] | ||
| 10-30mg q3-4h | | 10-30mg q3-4h | ||
| 0.1-0. | | 0.1-0.2mg/kg(up to 15mg q4h) | ||
|- | |- | ||
| [[Morphine]] (controlled release) | | [[Morphine]] (controlled release) | ||
| Start 30mg q8-12h , increase | | Start 30mg q8-12h , increase PRN to 90-120mg q12h | ||
| - | | - | ||
|- | |- | ||
| Línea 73: | Línea 78: | ||
{{General opioid chart}} | {{General opioid chart}} | ||
===Non-Opioid Analgesics Chart=== | |||
=== Non-Opioid Analgesics Chart | |||
{| class="wikitable" | {| class="wikitable" | ||
| Línea 247: | Línea 89: | ||
| [[Acetaminophen]] | | [[Acetaminophen]] | ||
| | | | ||
650- | 650-1000mg PO q4h | ||
1-2 g PO q4h | 1-2 g PO q4h | ||
| Línea 255: | Línea 97: | ||
|- | |- | ||
| [[Aspirin]] | | [[Aspirin]] | ||
| 650- | | 650-1000mg PO q4h | ||
| | | | ||
*Reye syndrome in children, tinnitus, central nervous system toxicity, metabolic acidosis | *Reye syndrome in children, tinnitus, central nervous system toxicity, metabolic acidosis | ||
|- | |- | ||
| [[Ibuprofen]] | | [[Ibuprofen]] | ||
| 400- | | 400-800mg PO q4-6h | ||
| | | | ||
*GI upset, platelet dysfunction, renal dysfunction, bronchospasm | *GI upset, platelet dysfunction, renal dysfunction, bronchospasm | ||
| Línea 266: | Línea 108: | ||
| [[Naproxen]] | | [[Naproxen]] | ||
| | | | ||
250mg PO q6-8h | |||
500- | 500-1000mg PR q6-8h | ||
| | | | ||
*GI upset, platelet dysfunction, renal dysfunction, bronchospasm plus interacts with protein-bound drugs<br> | *GI upset, platelet dysfunction, renal dysfunction, bronchospasm plus interacts with protein-bound drugs<br> | ||
|- | |- | ||
| Indomethacin | | [[Indomethacin]] | ||
| | | | ||
25- | 25-50mg PO q12h | ||
100mg PR q24h | |||
| | | | ||
| Línea 284: | Línea 126: | ||
| [[Ketorolac]] | | [[Ketorolac]] | ||
| | | | ||
15- | 15-30mg IV q6h | ||
30- | 30-60mg IM | ||
| | | | ||
| Línea 294: | Línea 136: | ||
{{Parenteral opioids chart}} | {{Parenteral opioids chart}} | ||
{{Oral opioid chart}} | |||
{ | |||
<div style="display:none"> | |||
<!-- SMW MedicationDose annotations for all medications on this page --> | |||
<!-- Step 1: Mild Pain (Non-opioid) --> | |||
{{MedicationDose|drug=Acetaminophen|dose=650 mg PO q4-6h PRN or 1000 mg PO q6h PRN|route=PO|context=Step 1 - Mild pain (non-opioid)|indication=Acute pain management|max_dose=4 g/day|notes=Risk of liver dysfunction and necrosis}} | |||
{{MedicationDose|drug=Aspirin|dose=650 mg PO q4-6h PRN or 1000 mg PO q6h PRN|route=PO|context=Step 1 - Mild pain (non-opioid)|indication=Acute pain management|notes=Reye syndrome in children; tinnitus, metabolic acidosis}} | |||
{{MedicationDose|drug=Ibuprofen|dose=400-800 mg PO q6-8h PRN|route=PO|context=Step 1 - Mild pain (NSAID)|indication=Acute pain management|max_dose=3200 mg/day|notes=GI upset, platelet dysfunction, renal dysfunction}} | |||
{{MedicationDose|drug=Gabapentin|dose=300 mg PO qhs (starting dose)|route=PO|context=Neuropathic pain adjuvant|indication=Acute pain management}} | |||
{{MedicationDose|drug=Naproxen|dose=250 mg PO q6-8h or 500-1000 mg PR q6-8h|route=PO/PR|context=Non-opioid analgesic (NSAID)|indication=Acute pain management|notes=GI upset, platelet dysfunction, renal dysfunction}} | |||
{{MedicationDose|drug=Indomethacin|dose=25-50 mg PO q12h or 100 mg PR q24h|route=PO/PR|context=Non-opioid analgesic (NSAID)|indication=Acute pain management|notes=GI upset, platelet dysfunction, renal dysfunction}} | |||
{{MedicationDose|drug=Ketorolac|dose=15-30 mg IV q6h or 30-60 mg IM|route=IV/IM|context=Non-opioid analgesic (NSAID, parenteral)|indication=Acute pain management|notes=Greater GI bleeding risk than ibuprofen; limit to 3 days IV, 5 days PO}} | |||
<!-- Step 2: Moderate Pain (Mild Opioids) --> | |||
{{MedicationDose|drug=Hydrocodone|dose=5-10 mg PO q4-6h PRN (with acetaminophen 325 mg)|route=PO|context=Step 2 - Moderate pain (mild opioid)|indication=Acute pain management}} | |||
{{MedicationDose|drug=Oxycodone|dose=5-10 mg PO q4-6h PRN|route=PO|context=Step 2 - Moderate pain (mild opioid)|indication=Acute pain management}} | |||
{{MedicationDose|drug=Codeine|dose=30-60 mg PO q3-4h|route=PO|context=Step 2 - Moderate pain (mild opioid)|indication=Acute pain management|notes=Some patients cannot convert to active metabolite}} | |||
{{MedicationDose|drug=Tramadol|dose=50-100 mg PO q4-6h|route=PO|context=Step 2 - Moderate pain (mild opioid)|indication=Acute pain management|onset=10-15 min|duration=4-6 hours|notes=CNS side effects; display=Tramadol (Ultram)}} | |||
<!-- Step 3: Severe Pain (Strong Opioids) --> | |||
{{MedicationDose|drug=Morphine|dose=0.1 mg/kg IV or 10 mg IM or 0.3 mg/kg PO; titrate 2-5 mg IV q5-10min|route=IV/IM/PO|context=Step 3 - Severe pain (1st line opioid)|indication=Acute pain management|onset=1-2 min (IV), 10-15 min (IM)|duration=1-2 hours (IV), 3-4 hours (IM)|notes=Histamine release may cause transient hypotension or nausea}} | |||
{{MedicationDose|drug=Hydromorphone|dose=0.015 mg/kg IV or 1-2 mg IM; titrate 0.5-1.0 mg IV increments|route=IV/IM|context=Step 3 - Severe pain (opioid)|indication=Acute pain management|onset=3-5 min (IV)|duration=2-4 hours (IV)|display=Hydromorphone (Dilaudid)}} | |||
{{MedicationDose|drug=Fentanyl|dose=1.0 mcg/kg IV; titrate 25-50 mcg IV q2-3min|route=IV|context=Step 3 - Severe pain (opioid, short-acting)|indication=Acute pain management|onset=<1 min (IV)|duration=30-60 min (IV)|notes=High doses (>5 mcg/kg) can cause chest wall rigidity}} | |||
{{MedicationDose|drug=Meperidine|dose=1.0-1.5 mg/kg IV/IM; titrate 12.5-50 mg IV increments|route=IV/IM|context=Step 3 - Severe pain (opioid, avoid if possible)|indication=Acute pain management|display=Meperidine (Demerol)|notes=Contraindicated with MAOIs; neurotoxic metabolite with repeated dosing}} | |||
{{MedicationDose|drug=Butorphanol|dose=0.5-2.0 mg IV; average 2 mg q3-4h|route=IV|context=Step 3 - Severe pain (mixed agonist-antagonist)|indication=Acute pain management|display=Butorphanol (Stadol)|notes=Mixed agonist-antagonist; may cause withdrawal in opioid-dependent patients}} | |||
</div> | |||
==See Also== | ==See Also== | ||
*[[ | *[[Opioid overdose]] | ||
*[[Opioid | *[[Opioid withdrawal]] | ||
*[[Analgesics_and_Sedatives_(Peds)|Analgesics and Sedatives (Pediatrics)]] | *[[Analgesics_and_Sedatives_(Peds)|Analgesics and Sedatives (Pediatrics)]] | ||
*[[Complex regional pain syndrome]] | |||
== | ==References== | ||
Adapted from Tintinalli and Harwood & Nuss, World Health Organization 3-Step Analgesia Ladder for Cancer & Washington Manual Intership Survival Guide, 2008 | Adapted from Tintinalli and Harwood & Nuss, World Health Organization 3-Step Analgesia Ladder for Cancer & Washington Manual Intership Survival Guide, 2008 | ||
[[Category:Misc/General]] | [[Category:Misc/General]] | ||
[[Category: | [[Category:Pharmacology]] | ||
[[Category:Palliative Medicine]] | |||
==References== | |||
<references/> | |||
[[Category:Symptoms]] | |||
Revisión actual - 10:56 22 mar 2026
Opioid Epidemic
- Consider that with a 10-day supply of an initial opioid prescription, the odds of still being on opioids a year later is ~20%[1]
- Consider opioid free regimens
WHO 3-step Ladder for Pain Control
| Agent | Oral | Parenteral |
|---|---|---|
| Step1. Mild Pain, Nonopioid, +/- Adjuvant | ||
| Acetaminophen | 650mg q4-q6h PRN or 1000mg q6h PRN | - |
| Aspirin | 650mg q4-6h PRN or 1000mg q6h PRN | - |
| Ibuprofen | 400-800mg q6-8h PRN | - |
| Gabapentin (neuropathic Pain) | Start 300mg qhs | - |
| Step2. Mod Pain, Opioid for mild/mod pain, +/-nonopioid, +/-Adjuvant | ||
| Hydrocodone (5mg/Acetaminophen 325mg) | 1-2 tabs PO q4-6h PRN | - |
| Oxycodone (5mg/Acetaminophen 325mg) | 1-2 tabs PO q4h PRN | - |
| Oxycodone (Oxycontin) | 5mg q4-6h | - |
| Tramadol | 50-100mg q4-6h (max 400mg/day) | - |
| Step3. Severe Pain, Opioid for mod/sev pain, +/- nonopioid, +/-Adjuvant | ||
| Morphine | 10-30mg q3-4h | 0.1-0.2mg/kg(up to 15mg q4h) |
| Morphine (controlled release) | Start 30mg q8-12h , increase PRN to 90-120mg q12h | - |
| Fentanyl | - | mcg/kg q1-3h |
| Hydromorphone (Dilaudid) | 2-4mg q4-6h | 1-4mg q4-6h |
| Levorphanol | 2mg q6-8h |
2mg q6-8h |
^In elders, use a bulk laxative and give instructions regarding activity, hydration and close follow-up
General Opioid Analgesics Chart
|
DRUG |
TYPICAL ADULT DOSE |
PHARMACOKINETICS |
COMMENTS |
|
0.1 mg/kg IV 10mg IM 0.3 mg/kg PO |
Onset: 1-2 min (IV), 10-15 min (IM/SC) Peak effect: 3-5 min (IV), 15-30 min (IM) Duration: 1-2 h (IV), 3-4 h (IM/SC) |
| |
|
(Dilaudid) |
0.015 mg/kg IV 1-2 mg IM |
Onset: 3-5 min (IV) Peak effect: 7-10 min (IV) Duration: 2-4 h (IV) |
|
|
1.0 mcg/kg IV |
Onset: <1 min (IV) Peak effect: 2-5 min (IV) Duration: 30-60 min (IV) |
| |
|
(Demerol) |
1.0-1.5 mg/kg IV/IM |
Onset: 5 min (IV) Peak effect: 5-10 min (IV) Duraction 2-3 h (IV) |
|
|
5-10 mg PO 30 mg PR |
Onset: 10-15 min (PO) Duration 3-6 h (PO) |
| |
|
5-10 mg PO |
Onset: 30-60 min (PO) Duraction 4-6 h (PO) |
| |
|
30-60 mg PO 30-100 mg IM |
Onset: 30-60 min (PO) Duraction: 4-6 h (PO) |
| |
|
(Ultram) |
50-100 mg PO |
Onset: 10-15 min (PO) Duration: 4-6 h (PO) |
|
Non-Opioid Analgesics Chart
DRUG
|
TYPICAL ADULT DOSE
|
COMMENTS
|
| Acetaminophen |
650-1000mg PO q4h 1-2 g PO q4h |
|
| Aspirin | 650-1000mg PO q4h |
|
| Ibuprofen | 400-800mg PO q4-6h |
|
| Naproxen |
250mg PO q6-8h 500-1000mg PR q6-8h |
|
| Indomethacin |
25-50mg PO q12h 100mg PR q24h |
|
| Ketorolac |
15-30mg IV q6h 30-60mg IM |
|
Parenteral Opioid Dosing Chart
| DRUG | ROUTE | DOSAGE | COMMENTS |
| Morphine | IV or IM |
Titrate 2-5 mg increments q5-10 min Peak analgesia in 10-20 min Average: 10 mg q3-4h |
Preferred first-line agent in most situations |
| Fentanyl | IV or IM |
Titrate 25-50 mcg increments q2-3 min Peak analgesia in 3-5 min Duration 30-60 min |
Ideal for short procedures No histamine release Typically not suitable for the ED |
|
(Demerol) |
IV |
Titrate 12.5-50 mg increments Peak analgesia in 5-10 min Average: 100 mg q2-3h |
Risk of unique CNS toxicity with repeated dosing IM injection is very irritating to tissue |
|
(Dilaudid) |
IV |
Titrate 0.5-1.0 mg increments Peak analgesia in 5-15 min Average: 1.5 mg q3-4h |
|
|
(Stadol) |
IV |
Titrate 0.5-2.0 mg increments Peak analgesia in 4-5 min Average: 2 mg q3-4h |
Mixed agonist-antagonist May be preferred in biliary colic |
Oral Opioid Dosing Chart
| DRUG | ANALGESIC EQUIVALENCE | USUAL STARTING DOSE | USUAL INTERVAL |
| Morphine (MSIR, Roxanol, others) | 30 mg | 15-30 mg | 3-4 h |
| Morphine: sustained release (MS Contin, Oramorph-SR) | 30 mg | 30 mg | 8-12 h |
| Meperidine (Demerol) | 300 mg | 50-100 mg | 2-3 h |
| Codeine (in Tylenol #3, others) | 200 mg | 30-60 mg | 3-4 h |
| Oxycodone (Roxicodone, also in Percocet, Percodan, Tylox, others) | 20-30 mg | 5-10 mg | 3-6 h |
| Hydrocodone (in Lorcet, Lortab, Vicodin, others) | 30 mg | 5-10 mg | 3-6 h |
| Hydromorphone (Dilaudid) | 7.5 mg | 4-8 mg | 2-3 h |
| Tramadol (Ultram) | N/A | 25-50 mg | 4-6 h |
See Also
- Opioid overdose
- Opioid withdrawal
- Analgesics and Sedatives (Pediatrics)
- Complex regional pain syndrome
References
Adapted from Tintinalli and Harwood & Nuss, World Health Organization 3-Step Analgesia Ladder for Cancer & Washington Manual Intership Survival Guide, 2008
References
- ↑ Rech MA, et al. Acute pain management in the Emergency Department: Use of multimodal and non-opioid analgesic treatment strategies. Am J Emerg Med. 2022 Aug;58:57-65. PMID 35636044

